MVCAX
Price
$32.73
Change
+$0.34 (+1.05%)
Updated
Jun 2 closing price
Net Assets
16.77B
TASMX
Price
$30.75
Change
+$0.06 (+0.20%)
Updated
Jun 2 closing price
Net Assets
637.11M
Interact to see
Advertisement

MVCAX vs TASMX

Header iconMVCAX vs TASMX Comparison
Open Charts MVCAX vs TASMXBanner chart's image
MVCAX vs TASMX Comparison Chart in %
View a ticker or compare two or three
VS
MVCAX vs. TASMX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and TASMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.8B vs. TASMX (637M). TASMX (1.21) and MVCAX (1.16) have matching dividends . MVCAX was incepted earlier than TASMX: MVCAX (25 years) vs TASMX (11 years). MVCAX (0.98) is less costly to investors than TASMX (0.81). TASMX is a more actively managed with annual turnover of: 48.00 vs. MVCAX (24.00). TASMX has a lower initial minimum investment than MVCAX: TASMX (0) vs MVCAX (1000). TASMX annual gain was more profitable for investors over the last year : 15.29 vs. MVCAX (9.57). MVCAX return over 5 years is better than : 9.01 vs. TASMX (-6.84).
MVCAXTASMXMVCAX / TASMX
Total Expense Ratio0.970.81120%
Annual Report Gross Expense Ratio0.980.81121%
Fund Existence25 years11 years-
Gain YTD7.71510.83471%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B637M2,637%
Annual Yield % from dividends1.161.2196%
Returns for 1 year9.5715.2963%
Returns for 3 years21.8318.36119%
Returns for 5 years9.01-6.84-132%
Returns for 10 years76.0927.89273%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCRVX15.850.18
+1.15%
NYLI CBRE Global Infrastructure Inv Cl
RYRIX56.44N/A
N/A
Rydex Retailing Inv
IMOWX23.87N/A
N/A
Voya MidCap Opportunities W
STSNX41.10N/A
N/A
Sterling Capital SmCp Val A
SHSKX67.94N/A
N/A
BlackRock Health Sciences Opps K